Trial · NCT01782937
An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
NCT01782937, Phase 3, Completed, Kyowa Kirin Co., Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis. Trials, record NCT01782937. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01782937
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
- NCT number
- NCT01782937
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 30 participants, actual
- Lead sponsor
- Kyowa Kirin Co., Ltd.
- Conditions
- Psoriasis
- Interventions
- KHK4827
- First posted
- 2013-02-04
- Last updated
- 2015-02-16
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical Global Impression (CGI) | 52 weeks | CGI is a 4-point scale that requires the investigators/subinvestigators to assess how much the subject's illness has improved or worsened relative to a baseline state. Scores on the scale are rated as: 1, remission; 2, improved; 3, no change; 4, worsened |
| Secondary | Percent improvement from baseline in Psoriasis Area and Severity Index (PASI) | 52 weeks | |
| Secondary | American College of Rheumatology (ACR) 20 (only in subjects with psoriasis arthritis) | 52 weeks | |
| Secondary | Pustular symptom score (only in subjects with pustular psoriasis) | 52 weeks | |
| Secondary | Static physician's global assessment (sPGA) of "clear or almost clear (0 or 1)" at Week 12 (only in subjects with psoriatic erythroderma) | 52 weeks | |
| Secondary | sPGA of "clear (0)" at Week 12 (only in subjects with psoriatic erythroderma) | 52 weeks | |
| Secondary | Body surface area involvement (BSA) of lesion at Week 12 (only in subjects with psoriatic erythroderma) | 52 weeks | |
| Secondary | Incidence and types of adverse events and adverse reactions | 52 weeks | |
| Secondary | Laboratory values and vital signs | 52 weeks | |
| Secondary | Profiles of pharmacokinetics | 52 weeks | Concentration of KHK4827 in serum |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01782937
GET https://conductscience.org/api/trials/v1/NCT01782937/registered